BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2132196)

  • 1. Apolipoprotein and lipid ratios in treated non-insulin dependent diabetics.
    Dean JD; Owens DR; Matthews SB
    Diabetes Res; 1990 Sep; 15(1):21-5. PubMed ID: 2132196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
    Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
    Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoproteins AI and B and plasma lipid values in well-treated diabetic patients from Romania.
    Dabelea D; Serban V; Băcanu G; Deutsch G; Pataki C; Dan I
    Rom J Intern Med; 1995; 33(3-4):249-56. PubMed ID: 8646198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein levels in normolipidemic non-insulin-dependent diabetes mellitus.
    Horng YC; Wei JS; Chang RS; Huang HS; Huang MJ; Huang BY
    J Formos Med Assoc; 1992 Jun; 91(6):590-4. PubMed ID: 1358344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
    Billingham MS; Milles JJ; Bailey CJ; Hall RA
    Diabetes Res; 1989 May; 11(1):13-20. PubMed ID: 2515931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
    Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
    Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Brunner D
    Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
    al-Muhtaseb N; al-Yusef AR; Bajaj JS
    Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of abnormal composition of lipoproteins to HbA1c levels in non-insulin dependent diabetes.
    Sánchez-Cabezudo M; Ródenas S; Cuesta C
    Rev Esp Fisiol; 1994 Sep; 50(3):145-51. PubMed ID: 7886271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein levels in non-insulin-dependent diabetes mellitus with clinical macroangiopathy.
    Ikeda T; Ohtani I; Fujiyama K; Hoshino T; Tanaka Y; Tekeuchi T; Mashiba H
    Diabete Metab; 1991; 17(3):373-8. PubMed ID: 1884882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
    Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
    Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study.
    Frénais R; Ouguerram K; Maugeais C; Mahot P; Maugère P; Krempf M; Magot T
    Diabetologia; 1997 May; 40(5):578-83. PubMed ID: 9165227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.
    Barbagallo CM; Averna MR; Amato S; Marino G; Labisi M; Rao AC; Barbagallo M; Cupidi GF; Notarbartolo A
    Acta Diabetol Lat; 1990; 27(4):371-7. PubMed ID: 2087939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoproteins and lipoproteins in children with type I diabetes: relation to glycosylated serum protein and HbA1.
    Strobl W; Widhalm K; Schober E; Frisch H; Pollak A; Westphal G
    Acta Paediatr Scand; 1985 Nov; 74(6):966-71. PubMed ID: 4090971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
    Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density lipoprotein cholesterol and apolipoprotein a-1 concentrations in non-insulin dependent diabetics treated by diet and chlorpropamide.
    Billingham MS; Leatherdale BA; Hall RA; Bailey CJ
    Diabete Metab; 1982 Sep; 8(3):229-33. PubMed ID: 6814965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
    Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein abnormalities in well-treated type II diabetic patients.
    Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
    Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.